Education
About Us
Working with TipRanks
Follow Us
PAUL HARTMANN AG (DE:PHH2)
FRANKFURT:PHH2
PHH2 Stock Chart & Stats
€214.00
-€4.00(-1.75%)
At close: 4:00 PM EST
€214.00
-€4.00(-1.75%)
Day’s Range― - ―
52-Week Range€213.00 - €258.00
Previous CloseN/A
Volume0.00
Average Volume (3M)69.00
Market Cap
€760.07M
Enterprise Value€937.22M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)9.3
Beta0.23
Next Earnings
Mar 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)18.48
Shares Outstanding3,572,424
10 Day Avg. Volume67
30 Day Avg. Volume69
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PHH2 FAQ
What was PAUL HARTMANN AG’s price range in the past 12 months?
PAUL HARTMANN AG lowest stock price was €213.00 and its highest was €258.00 in the past 12 months.
What is PAUL HARTMANN AG’s market cap?
PAUL HARTMANN AG’s market cap is €760.07M.
When is PAUL HARTMANN AG’s upcoming earnings report date?
PAUL HARTMANN AG’s upcoming earnings report date is Mar 19, 2026 which is in 12 days.
How were PAUL HARTMANN AG’s earnings last quarter?
PAUL HARTMANN AG released its earnings results on Mar 20, 2025. The company reported €18.484 earnings per share for the quarter, beating the consensus estimate of N/A by €18.484.
Is PAUL HARTMANN AG overvalued?
According to Wall Street analysts PAUL HARTMANN AG’s price is currently Overvalued.
Does PAUL HARTMANN AG pay dividends?
PAUL HARTMANN AG does not currently pay dividends.
What is PAUL HARTMANN AG’s EPS estimate?
PAUL HARTMANN AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PAUL HARTMANN AG have?
PAUL HARTMANN AG has 3,572,424 shares outstanding.
What happened to PAUL HARTMANN AG’s price movement after its last earnings report?
PAUL HARTMANN AG reported an EPS of €18.484 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.684%.
Which hedge fund is a major shareholder of PAUL HARTMANN AG?
Currently, no hedge funds are holding shares in DE:PHH2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
PAUL HARTMANN AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
8.49%
12-Months-Change
Fundamentals
Return on Equity
7.37%
Trailing 12-Months
Asset Growth
5.30%
Trailing 12-Months
Company Description
PAUL HARTMANN AG
Paul Hartmann AG engages in the production of medical and hygiene products. It operates through Wound Management, Incontinence Management and Infection Management and other segments. The Wound segment comprises wound dressing and treatment, compression therapy, first aid, immobilization, and diagnostics. The Incontinence segment provides incontinence hygiene, patient care, and medical skin care. The Infection segment consists of custom procedure trays, surgical draping systems, disposable surgical instruments, and disinfectants. The Other activities include activities in cotton-wool products, medical consumer goods and pharmaceutical products and others. All the activities are functioned through the region of US and derive revenue through the sale of medical and hygiene products.
Technical Analysis
Biotest
―
CompuGroup Medical
―
Draegerwerk AG & Co. KGaA
―
RHON-KLINIKUM AG
―
Medios AG
―
Options Prices
Currently, No data available
---